Anti-TNF-alpha Biosimilars Humira, Remicade and Enbrel

1st March 2012

Category: Biosimilars

Tags: Anti-TNF-alpha, Biosimilars, Enbrel, Humira, Remicade

By: Dr Daniel Galbraith, CSO,

Anti Tumor Necrosis Factor (Anti-TNF) drugs, Humira (adalimumab), Remicade (infliximab) and Enbrel (etanercept) are perhaps the most successful of all biologics both with respect to their turnover and the number of patients treated with these drugs. All have been shown in clinical trials to help with improving the clinical outcome of Rheumatoid Arthritis (RA) but More